[Urologic Oncology Study Society. Promotor and facilitator of uro-oncologic clinical research]
- PMID: 17701155
- DOI: 10.1007/s00120-007-1506-3
[Urologic Oncology Study Society. Promotor and facilitator of uro-oncologic clinical research]
Similar articles
-
Open clinical uro-oncology trials in Canada.Can J Urol. 2009 Apr;16(2):4617-23. Can J Urol. 2009. PMID: 19364441 No abstract available.
-
The history and future of the Urologic Oncology Study Group (UOSG) of the Japan Clinical Oncology Group (JCOG).Jpn J Clin Oncol. 2012 May;42(5):363-7. doi: 10.1093/jjco/hys040. Epub 2012 Mar 26. Jpn J Clin Oncol. 2012. PMID: 22450928 Review.
-
Systemic therapy for metastatic urothelial carcinoma.BJU Int. 2008 Apr;101(7):795-803. doi: 10.1111/j.1464-410X.2007.07356.x. Epub 2007 Dec 5. BJU Int. 2008. PMID: 18070193 Review. No abstract available.
-
Clinical trials in adult AML.Clin Adv Hematol Oncol. 2009 Jun;7(6):8-10. Clin Adv Hematol Oncol. 2009. PMID: 19645130 Review. No abstract available.
-
Development of growth inhibitory agents in urological and other malignancies.BJU Int. 2006 Sep;98(3):497-502. doi: 10.1111/j.1464-410X.2006.06259.x. Epub 2006 Jul 7. BJU Int. 2006. PMID: 16827906 Review. No abstract available.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources